Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.
2.
3.

[3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.

Wright RA, Arnold MB, Wheeler WJ, Ornstein PL, Schoepp DD.

J Pharmacol Exp Ther. 2001 Aug;298(2):453-60.

4.

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.

Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP, Belagaje R, Wu S, Schoepp DD.

Neuropharmacology. 1998;37(1):1-12.

PMID:
9680254
5.

Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.

Monn JA, Valli MJ, Massey SM, Hansen MM, Kress TJ, Wepsiec JP, Harkness AR, Grutsch JL Jr, Wright RA, Johnson BG, Andis SL, Kingston A, Tomlinson R, Lewis R, Griffey KR, Tizzano JP, Schoepp DD.

J Med Chem. 1999 Mar 25;42(6):1027-40.

PMID:
10090786
6.

Endogenous activation of group-II metabotropic glutamate receptors inhibits the hypothalamic-pituitary-adrenocortical axis.

Scaccianoce S, Matrisciano F, Del Bianco P, Caricasole A, Di Giorgi Gerevini V, Cappuccio I, Melchiorri D, Battaglia G, Nicoletti F.

Neuropharmacology. 2003 Apr;44(5):555-61.

PMID:
12668041
7.

Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.

Cartmell J, Adam G, Chaboz S, Henningsen R, Kemp JA, Klingelschmidt A, Metzler V, Monsma F, Schaffhauser H, Wichmann J, Mutel V.

Br J Pharmacol. 1998 Feb;123(3):497-504.

8.

Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.

Schaffhauser H, Rowe BA, Morales S, Chavez-Noriega LE, Yin R, Jachec C, Rao SP, Bain G, Pinkerton AB, Vernier JM, Bristow LJ, Varney MA, Daggett LP.

Mol Pharmacol. 2003 Oct;64(4):798-810.

9.

Pharmacological profiles of the metabotropic glutamate receptor ligands.

Naples MA, Hampson DR.

Neuropharmacology. 2001;40(2):170-7.

PMID:
11114395
10.

Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections.

Mutel V, Ellis GJ, Adam G, Chaboz S, Nilly A, Messer J, Bleuel Z, Metzler V, Malherbe P, Schlaeger EJ, Roughley BS, Faull RL, Richards JG.

J Neurochem. 2000 Dec;75(6):2590-601.

11.

Synthesis and structure-activity relationship studies of novel 2-diarylethyl substituted (2-carboxycycloprop-1-yl)glycines as high-affinity group II metabotropic glutamate receptor ligands.

Sørensen US, Bleisch TJ, Kingston AE, Wright RA, Johnson BG, Schoepp DD, Ornstein PL.

Bioorg Med Chem. 2003 Jan 17;11(2):197-205.

PMID:
12470714
12.

Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.

Arcella A, Carpinelli G, Battaglia G, D'Onofrio M, Santoro F, Ngomba RT, Bruno V, Casolini P, Giangaspero F, Nicoletti F.

Neuro Oncol. 2005 Jul;7(3):236-45.

13.

Characterization of [(3)H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using semliki forest virus vectors.

Schweitzer C, Kratzeisen C, Adam G, Lundstrom K, Malherbe P, Ohresser S, Stadler H, Wichmann J, Woltering T, Mutel V.

Neuropharmacology. 2000 Jul 24;39(10):1700-6.

PMID:
10884552
14.

[3H]LY341495, a highly potent, selective and novel radioligand for labeling Group II metabotropic glutamate receptors.

Ornstein PL, Arnold MB, Bleisch TJ, Wright RA, Wheeler WJ, Schoepp DD.

Bioorg Med Chem Lett. 1998 Jul 21;8(14):1919-22.

PMID:
9873459
15.

(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord.

Thomas NK, Wright RA, Howson PA, Kingston AE, Schoepp DD, Jane DE.

Neuropharmacology. 2001 Mar;40(3):311-8.

PMID:
11166323
16.

Characterization of metabotropic glutamate receptors in rat C6 glioma cells.

Albasanz JL, Ros M, Martín M.

Eur J Pharmacol. 1997 May 12;326(1):85-91.

PMID:
9178659
17.

Comparative effect of L-CCG-I, DCG-IV and gamma-carboxy-L-glutamate on all cloned metabotropic glutamate receptor subtypes.

Brabet I, Parmentier ML, De Colle C, Bockaert J, Acher F, Pin JP.

Neuropharmacology. 1998 Aug;37(8):1043-51.

PMID:
9833633
18.

The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity.

Fitzjohn SM, Bortolotto ZA, Palmer MJ, Doherty AJ, Ornstein PL, Schoepp DD, Kingston AE, Lodge D, Collingridge GL.

Neuropharmacology. 1998 Dec;37(12):1445-58.

PMID:
9886667
19.

The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.

Ngomba RT, Biagioni F, Casciato S, Willems-van Bree E, Battaglia G, Bruno V, Nicoletti F, van Luijtelaar EL.

Neuropharmacology. 2005;49 Suppl 1:89-103.

PMID:
16043198
20.

mGLU3 metabotropic glutamate receptors modulate the differentiation of SVZ-derived neural stem cells towards the astrocytic lineage.

Ciceroni C, Mosillo P, Mastrantoni E, Sale P, Ricci-Vitiani L, Biagioni F, Stocchi F, Nicoletti F, Melchiorri D.

Glia. 2010 May;58(7):813-22. doi: 10.1002/glia.20965.

PMID:
20091783

Supplemental Content

Support Center